HIC
Hartline Investment Corp’s Novo Nordisk NVO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-1,620
| Closed | -$231K | – | 103 |
|
2024
Q2 | $231K | Sell |
1,620
-15,754
| -91% | -$2.25M | 0.03% | 93 |
|
2024
Q1 | $2.23M | Buy |
+17,374
| New | +$2.23M | 0.39% | 49 |
|
2018
Q2 | – | Sell |
-69,622
| Closed | -$3.43M | – | 102 |
|
2018
Q1 | $3.43M | Sell |
69,622
-7,910
| -10% | -$390K | 0.94% | 28 |
|
2017
Q4 | $4.16M | Sell |
77,532
-2,825
| -4% | -$152K | 1.15% | 22 |
|
2017
Q3 | $3.87M | Sell |
80,357
-1,675
| -2% | -$80.6K | 1.17% | 20 |
|
2017
Q2 | $3.52M | Sell |
82,032
-1,425
| -2% | -$61.1K | 1.12% | 23 |
|
2017
Q1 | $2.86M | Sell |
83,457
-650
| -0.8% | -$22.3K | 0.92% | 33 |
|
2016
Q4 | $3.02M | Sell |
84,107
-14,695
| -15% | -$527K | 1.05% | 26 |
|
2016
Q3 | $4.11M | Buy |
98,802
+455
| +0.5% | +$18.9K | 1.48% | 14 |
|
2016
Q2 | $5.29M | Sell |
98,347
-1,060
| -1% | -$57K | 1.9% | 12 |
|
2016
Q1 | $5.39M | Sell |
99,407
-1,030
| -1% | -$55.8K | 1.96% | 9 |
|
2015
Q4 | $5.83M | Buy |
100,437
+12,242
| +14% | +$711K | 2.18% | 10 |
|
2015
Q3 | $4.78M | Buy |
88,195
+50
| +0.1% | +$2.71K | 1.74% | 15 |
|
2015
Q2 | $4.83M | Sell |
88,145
-1,575
| -2% | -$86.3K | 1.61% | 14 |
|
2015
Q1 | $4.79M | Sell |
89,720
-7,075
| -7% | -$378K | 1.57% | 17 |
|
2014
Q4 | $4.1M | Buy |
96,795
+360
| +0.4% | +$15.2K | 1.37% | 21 |
|
2014
Q3 | $4.59M | Sell |
96,435
-1,050
| -1% | -$50K | 1.65% | 12 |
|
2014
Q2 | $4.5M | Sell |
97,485
-12,175
| -11% | -$562K | 1.62% | 13 |
|
2014
Q1 | $5.01M | Buy |
109,660
+96,485
| +732% | +$4.4M | 1.71% | 11 |
|
2013
Q4 | $2.43M | Sell |
13,175
-100
| -0.8% | -$18.5K | 0.85% | 45 |
|
2013
Q3 | $2.25M | Buy |
13,275
+200
| +2% | +$33.8K | 0.88% | 44 |
|
2013
Q2 | $2.03M | Buy |
+13,075
| New | +$2.03M | 0.82% | 46 |
|